Word

BIOTEST

Status

Dead

Status Code

710

Status Date

Friday, January 15, 2016

Serial Number

76374498

Registration Number

2961650

Registration Date

Tuesday, June 14, 2005

Mark Type

3000

Filing Date

Thursday, February 21, 2002

Published for Opposition

Tuesday, March 22, 2005

Cancellation Date

Friday, January 15, 2016

Trademark Owner History

BIOTEST AG - Original Registrant

Classifications

1 [ In-vitro diagnostic preparations for scientific purposes; test kits comprising reagents, sera, monoclonal and polyclonal antibodies, natural and recombinant antigens, and microtiter plates, and reagents for scientific and research purposes; systems for determining resistance for scientific purposes comprising nutrient media, cell culture media, and dried media; buffers, salts, solvents for research and scientific purposes; test kits comprising buffers, salts, solvents and reagents for industrial and scientific purposes for hygiene monitoring on surfaces, in air and liquids, and systems for identification of germs for scientific and research purposes comprising nutrient media, buffers and salts; DNA probes for tissue typing, germ or pathogen identification and blood group determination ]

5 [ Pharmaceutical and veterinary preparations and products for treating immune insufficiencies, especially autoimmune insufficiencies, cancer, virus infections, conditions of virus reactivation, anemia, protein anemia, immune globulin anemia, blood coagulation disorders, and deficiencies in blood coagulation factors, or for preventing rejections in transplantation medicine; food for babies; medical plasters; materials for wound, burn or surgical dressing; pharmaceutical preparations for hematology, oncology, transplantation medicine, nephrology, pediatrics, for intensive care medicine, namely, blood products, immune globulin preparations, globulin preparations, coagulation factors; medicines for use in transplantation procedures and for influencing blood coagulation; immune globulin preparations for treating immune insufficiencies, especially autoimmune insufficiencies, cancer, virus infections, conditions of virus reactivation, anemia, protein anemia, immune globulin anemia, blood coagulation disorders, and deficiencies in blood coagulation factors, or for preventing rejections in transplantation medicine; serum preparations, and serum proteins and solutions comprising the same for medical use; human albumin for medical use; blood products for medical use, namely, blood plasma; blood substitutes; plasma substitutes and plasma expanders; vaccines, especially on basis of immune globulines; blood coagulation preparations, especially coagulation factors for clinical and medical laboratory use; antibiotics; medicines for treating the central nervous system; medicines for treating heart and circulation diseases; medicines for treating the respiratory system; medicines for urological treatment; medicines for treatment of digestive organs and corresponding/adjoining glands; hormones; vitamins; immunosuppressive, anti-inflammatory, and antiallergic medicines; dermatological, ophtalmological and otological medicines; in-vivo and in-vitro diagnostic preparations for clinical or medical purposes and clinical or medical laboratory use; antibodies, namely, mono- and polyclonal antibodies for use in in-vivo clinical and medical diagnostics and for patient therapy; in vitro diagnostic agents for medical purposes, especially for determination of proteins, such as antibodies, monoclonal antibodies or immune globulins, or for determinations of nucleic acids, for blood group diagnostics and antibody determination, tissue typing, cell diagnostics, microbiological diagnostics, and determination of toxic compounds; test kits comprising ready to use nutrient media for microorganisms, especially bacteria, and reagents for medical and laboratory uses, especially for blood group diagnostics, antibody determination, tissue typing, cell diagnostics, microbiological diagnostics, determination of toxic substances; test kits comprising monoclonal and polyclonal antibodies and natural and recombinant antigenes, for tests on serological and immune genetic basis, and reagents therefore for human and veterinary medical laboratory purposes; immunoassays such as ELISA's, consisting of reagents, sera, monoclonal and polyclonal antibodies, natural and recombinant antigens, and microtiter plates, and reagents therefore for human and veterinary medical laboratory purposes; diagnostic preparations for human or veterinary medical uses in the treatment of infections; media for bacteriological cultures, namely, ready-to-use culture media and nutrient media and ingredients thereof ]

9 [ Plates and multiwell microtiter plates for cell typing, blood and virus diagnostics; blood warmers; apparatus, namely, incubator, cell sorter, cell counter, shaker, pipettes, plates and vials for cell recovery and for handling of cells, including disposable materials; ] measuring and surveying apparatus, namely, [ sample holder, reader, photometer, centrifuge, shaker, incubator, washer, particle counter ] and air sampler for removal, determination and quantification of microorganisms in air, [ liquids ] and on surfaces; [ measuring and surveying kits/systems and agar strips for determination and quantification of substances, namely, blood sugar, blood and respiratory alcohol, toxic substances, oxygen and blood constituents such as hemoglobin; ] kits/systems comprising agar strips, air samplers, [ particle counters, anemometers ] and agar strips for determination of air borne germs and for sanitary and hygiene monitoring, [ laboratory robot, for automated processing of microtiter plate based assays like ELISAs, DNA hybridization assays and cell agglutination tests; ] kits/systems comprising agar strips, air samplers, [ particle counters, anemometers ] and agar strips for determination of air borne germs and for determination of particle size and number in air; kits/systems comprising air samplers, sample holders and reader for clean room air monitoring; all the foregoing for use in research and/or non-medical laboratories

10 [ Medical, apparatus for clinical or diagnostic use, namely, apparatus for serological blood typing, blood grouping or serological detection of blood groups; bottles and containers specially designated for storage and conservation of solutions for transfusions and infusions; transfusion and infusion apparatus and devices, namely, containers, syringes, catheters, transdermal delivery systems comprising blood warmers and plasma for clinical use; apparatus for cell recovery and for handling of cells, including disposable materials, namely, plates, spatula, vials, pipette tips and beakers for clinical or diagnostic use; measuring and surveying apparatus for clinical and diagnostic use, namely, sample holder, reader, photometer, dipsticks, teststrips, and agar strips for determination and quantification of substances, especially blood sugar, blood and respiratory alcohol, toxic substances, oxygen and blood constituents such as hemoglobin; plates and multiwell microtiter plates for cell typing, blood and virus diagnostics for clinical and diagnostic use; all of the foregoing for medical, clinical, diagnostic and/or surgical use ]

The mark consists of the word BIOTEST proximate a red triangle device with a red ball or circle at each of the vertices of the triangle device. The word portion of the mark is in black ink.
Color is a feature of the mark. The mark is lined for the color red.

Trademark Events

Jan 15, 2016

Cancelled Sec. 8 (10-Yr)/Expired Section 9

Jul 28, 2011

Notice Of Acceptance Of Sec. 8 & 15 - Mailed

Jul 27, 2011

Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed

Jul 27, 2011

Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.

Jun 14, 2011

Registered - Sec. 8 (6-Yr) & Sec. 15 Filed

Jul 26, 2011

Case Assigned To Post Registration Paralegal

Jun 14, 2011

Teas Section 8 & 15 Received

Nov 3, 2008

Applicant/Correspondence Changes (Non-Responsive) Entered

Nov 3, 2008

Teas Change Of Owner Address Received

Oct 23, 2008

Ttab Release Case To Trademarks

Oct 23, 2008

Cancellation Terminated No. 999999

Oct 23, 2008

Cancellation Dismissed No. 999999

Jan 6, 2008

Cancellation Instituted No. 999999

Jun 14, 2005

Registered-Principal Register

Mar 22, 2005

Published For Opposition

Mar 2, 2005

Notice Of Publication

Dec 29, 2004

Law Office Publication Review Completed

Oct 28, 2004

Approved For Pub - Principal Register

Aug 24, 2004

Examiner's Amendment Entered

Aug 27, 2004

Assigned To Lie

Aug 25, 2004

Assigned To Lie

Aug 25, 2004

Examiners Amendment Mailed

May 7, 2004

Correspondence Received In Law Office

May 7, 2004

Paper Received

Feb 9, 2004

Non-Final Action Mailed

Oct 20, 2003

Correspondence Received In Law Office

Nov 17, 2003

Case File In Ticrs

Oct 20, 2003

Paper Received

Apr 24, 2003

Final Refusal Mailed

Jan 16, 2003

Correspondence Received In Law Office

Jan 16, 2003

Paper Received

Jul 18, 2002

Non-Final Action Mailed

Jun 14, 2002

Assigned To Examiner